Dr. David H Leslie

DMD | Dentist



  
  6060 43rd Ave W, Bradenton
  Florida, 34209-6620

  941-795-8100    941-795-4959 Maps & Directions
Dr. David H Leslie is a Bradenton, Florida based Dentist who is specialized in General Practice Dentistry. He may accept the Medicare-approved amount. Patients may be billed for more than the Medicare deductible and coinsurance. His current practice location is 6060 43rd Ave W, Bradenton. Patients can reach him at 941-795-8100.
Dr. David H Leslie is the primary dental care provider for patients of all ages. He is responsible for the diagnosis, treatment, management and overall coordination of services related to patients' oral health needs.
Complete Profile:
Dr. David H Leslie speciality, credentials, practice address, contact phone number and fax are as below. Patients can directly walk in or can call on the below given phone number for appointment.
Name: Dr. David H Leslie
Specialization: Dentist
Gender:Male
Credentials: DMD
Accepts Medicare Assignment:May Accept
Practice Address:6060 43rd Ave W, Bradenton,
Florida, 34209-6620
Phone:941-795-8100
Fax:941-795-4959
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS). NPI details are as mentioned below.
PAC ID: 5799829099
Enrollment ID: I20150506001273
NPI Number: 1538224126
NPI Enumeration Date: 26 Dec, 2006
NPI Last Update On: 24 Sep, 2009

Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address: 6060 43rd Ave West,
Bradenton, Florida
Zip: 34209
Phone Number: 941-795-8100
Fax Number: 941-795-4959
Patients can reach Dr. David H Leslie at 6060 43rd Ave W, Bradenton, Florida or can call to book an appointment on 941-795-8100. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 November, 2024.

Comments/ Reviews: